ALKERMES | ALKS - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
AbbVie 23.96 0.93 2026-06
Acadia Pharmaceuticals 11.33 1.25 2026-06
ALKERMES 135.81 96.48 2026-06
Amgen 18.07 1.77 2026-06
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Eli Lilly 32.9 7.37 2026-06
Gilead Sciences 13.51 4.2 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 29.43 4.9 2026-06
Malin Corporation 11.81 0.72 2023-06
Merck 32.26 15.74 2026-06
Neurocrine Biosciences 22.1 5.99 2026-06
Otsuka Holdings 13 1.31 2026-06
Ovoca Bio 1.83 3.29 2024-06
Pfizer 11.48 2.16 2026-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Vertex Pharmaceuticals 28.05 2.22 2026-06